SS
Sanket Sharad Mehta
About Sanket Sharad Mehta
Data last updated:
Sanket Sharad Mehta has 14 years in corporate governance. Holds Designated Partner and Director roles. Currently with 6 companies, including Pred Healthcare Solutions Llp and Specialty Surgical Oncology Llp. Formerly with 3 companies, such as Asha Oncocare Foundation and Coral Laboratories Limited. Engaged in Healthcare, General Business. Contributes to corporate operations. The 4 current companies with reported revenue have a combined latest revenue of ₹105 Cr; the largest is Cytocure Medicare Private Limited at ₹55.94 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Cytocure Medicare Private Limited U85300MH2019PTC319108 | Director | 07 Jan 2019 | 2019 | ₹55.94 Cr (FY 2025) | Active |
| Vatsalya Healthcare Llp AAO-4683 | Partner | 08 Oct 2024 | 2019 | ₹40.35 Cr (FY 2020) | Active |
| Spj Onco Care Private Limited U74999MH2018PTC317531 | Director | 28 Nov 2018 | 2018 | ₹8.88 Cr (FY 2025) | Active |
| Specialty Surgical Oncology Llp AAY-2223 | Designated Partner | 17 Aug 2021 | 2021 | ₹89,520 (FY 2023) | Active |
| Specialty Histopathology Llp AAZ-7827 | Designated Partner | 07 Dec 2021 | 2021 | – | Active |
| Pred Healthcare Solutions Llp AAY-1222 | Designated Partner | 09 Aug 2021 | 2021 | – | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Asha Oncocare Foundation U85300MH2019NPL332937 | Director | 14 Nov 2019 | 2019 | ₹7.6 Lakh (FY 2025) | Active |
 Coral Laboratories Limited L24231MH1997PLC422233 | Director | 26 May 2017 | 1997 | ₹124 Cr (FY 2025) | Active |
| Oncology Care Associates Llp AAB-1035 | Designated Partner | 05 Sep 2012 | 2012 | ₹2.5 Lakh (FY 2021) | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sanket Sharad Mehta
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sanket Sharad Mehta
Sanket Sharad Mehta has 14 years in corporate governance. Holds Designated Partner and Director roles. Currently with 6 companies, including Pred Healthcare Solutions Llp and Specialty Surgical Oncology Llp. Formerly with 3 companies, such as Asha Oncocare Foundation and Coral Laboratories Limited. Engaged in Healthcare, General Business. Contributes to corporate operations. The 4 current companies with reported revenue have a combined latest revenue of ₹105 Cr; the largest is Cytocure Medicare Private Limited at ₹55.94 Cr (FY 2025).
Sanket Sharad Mehta is associated with 6 companies as Designated Partner and Director, including Cytocure Medicare Private Limited (₹55.94 Cr), Vatsalya Healthcare Llp (₹40.35 Cr), Spj Onco Care Private Limited (₹8.88 Cr).
Sanket Sharad Mehta has expertise in Healthcare, General Business.
Sanket Sharad Mehta has 14 years in corporate governance.
By reported revenue, the largest current company of Sanket Sharad Mehta is Cytocure Medicare Private Limited, with revenue of ₹55.94 Cr (FY 2025).
The 4 current companies of Sanket Sharad Mehta that report revenue have a combined latest revenue of ₹105 Cr.
Sanket Sharad Mehta currently holds positions at 6 companies; the 5 largest by reported revenue are Cytocure Medicare Private Limited (₹55.94 Cr), Vatsalya Healthcare Llp (₹40.35 Cr), Spj Onco Care Private Limited (₹8.88 Cr), Specialty Surgical Oncology Llp (₹89,520), Specialty Histopathology Llp.